5 completed, 2 recruiting, 2 terminated, 2 unknown. 3 Not applicable, 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Terminated 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 3 | Not yet recruiting 1, Recruiting 1, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
Follow Cancer of Kidney: new trials by email Literature Review of Cancer of Kidney trials Research Report on Cancer of Kidney
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder Psilocybin therapy - Adjustment Disorder, Adjustment Disorder With Anxious Mood | Phase 2 | Recruiting | Psyence Australia Pty Ltd | 87 | 2025-10-01 | 2026-10-29 |
| Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy valveless trocar, standard trocar - Cancer of Kidney | Not applicable | Unknown | Regina Elena Cancer Institute | 66 | 2023-02-08 | 2023-02-17 |
| Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients Cabozantinib, Blood sample, Questionnaires of quality of life - Cancer of Kidney | Phase 2 | Not yet recruiting | Centre Hospitalier Universitaire de Besancon | 24 | 2022-06-01 | 2022-06-01 |
| A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of Southwest Finland. Renal Cell Cancer, Renal Cell Carcinoma | Completed | Pfizer | 1112 | 2022-05-02 | 2024-10-01 | |
| Tempus Priority Study: A Pan-tumor Observational Study Observation - Breast Cancer, Prostate Cancer | Active not recruiting | Tempus AI | 1000 | 2020-10-19 | 2025-05-06 | |
| Low-moderate Intensity Pedaling During Immunotherapy Administration Pedaling Group - Cancer of Skin, Cancer of Kidney | Not applicable | Withdrawn | Rush University Medical Center | 2020-01-31 | 2022-09-23 | |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) Cancer, All Types, Cancer of Liver | Unknown | SpeciCare | 1000 | 2019-03-21 | 2020-12-04 | |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry Clinical Trial Matching - Cancer, Metastatic, Cancer | Recruiting | Massive Bio, Inc. | 50000 | 2018-01-01 | 2025-10-28 | |
| Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) Radiation Therapy, Cancer | Completed | DxTerity Diagnostics | 16 | 2017-04-06 | 2024-08-07 | |
| MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors MEDI4736 - Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer | Phase 2 | Terminated | Washington University School of Medicine | 4 | 2016-09-12 | 2018-11-06 |
| Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pas de Calais , Normandy and Picardy Regions Cancer of Kidney | Completed | Centre Hospitalier Universitaire, Amiens | 2500 | 2014-11-17 | 2026-04-28 | |
| Microwave Coagulation in Partial Nephrectomy Protocol Microwave pre-coagulation - Cancer of Kidney | Not applicable | Terminated | University of Wisconsin, Madison | 2 | 2014-08-01 | 2018-02-26 |
| A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors Metformin XR, Delayed Metformin, Sirolimus - Breast Neoplasms, Lung Neoplasms | Phase 1 | Completed | University of Chicago | 24 | 2014-04-01 | 2019-04-22 |
| Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. 124-Iodine-cG250 (124I-cG250) - Cancer of Kidney, Kidney Cancer | Phase 1 | Completed | Ludwig Institute for Cancer Research | 26 | 2005-06-01 | 2022-10-10 |
Kidney Neoplasms (14) · Breast Neoplasms (6) · Neoplasms (6) · Pancreatic Neoplasms (6) · Liver Neoplasms (5) · Prostatic Neoplasms (5) · Stomach Neoplasms (5) · Urinary Bladder Neoplasms (5) · Colonic Neoplasms (4) · Esophageal Neoplasms (4) · Lung Neoplasms (4) · Ovarian Neoplasms (4) · Rectal Neoplasms (4) · Skin Neoplasms (4) · Uterine Cervical Neoplasms (4)
Female Urogenital Diseases (14) · Female Urogenital Diseases and Pregnancy Complications (14) · Kidney Diseases (14) · Male Urogenital Diseases (14) · Neoplasms by Site (14) · Urogenital Diseases (14) · Urogenital Neoplasms (14) · Urologic Diseases (14) · Urologic Neoplasms (14) · Digestive System Diseases (8) · Neoplasms (8) · Digestive System Neoplasms (7) · Neoplasms by Histologic Type (7) · Skin Diseases (7) · Skin and Connective Tissue Diseases (7)
Blood Specimen Collection (1) · Observation (1) · Sirolimus (1) · cabozantinib (1) · durvalumab (1)
Centre Hospitalier Universitaire de Besancon (1) · Centre Hospitalier Universitaire, Amiens (1) · DxTerity Diagnostics (1) · Ludwig Institute for Cancer Research (1) · Massive Bio, Inc. (1) · Pfizer (1) · Psyence Australia Pty Ltd (1) · Regina Elena Cancer Institute (1) · Rush University Medical Center (1) · SpeciCare (1) · Tempus AI (1) · University of Chicago (1) · University of Wisconsin, Madison (1) · Washington University School of Medicine (1)
United States (9) · France (2) · Australia (1) · Finland (1) · Italy (1) · Puerto Rico (1)
Bruno Hurault de Ligny, MD, PhD (1) · Chaitanya R Divgi, MD (1) · E Jason Abel, MD (1) · Gabriel Choukroun, MD, PhD (1) · Ken Dixon, MD (1) · Kristiyana Kaneva, MD, MS, MBA (1) · Manish Sharma, M.D. (1) · Marc Hazzan, MD, PhD (1) · Michel Godin, MD, PhD (1) · Neil Maresky (1) · Pual Russo, MD (1) · Ramaswamy Govindan, M.D. (1) · Selin Kurnaz, PhD (1) · Timothy M Kuzel, MD (1)